# Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

> **NCT00311090** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 757 (actual)

## Conditions studied

- Deep Venous Thrombosis

## Interventions

- **DRUG:** Idrabiotaparinux sodium
- **DRUG:** Idraparinux sodium
- **DRUG:** Avidin
- **DRUG:** Placebo (for Avidin)

## Key facts

- **NCT ID:** NCT00311090
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-01
- **Final completion:** 2008-01
- **Target enrollment:** 757 (ACTUAL)
- **Last updated:** 2016-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311090, "Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00311090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*